Eli Lilly announced a $6 billion investment in a manufacturing campus in northern Alabama to boost production of its next-generation medicines for obesity and metabolic diseases.

This project is part of Eli Lilly’s broader U.S. manufacturing expansion to meet rising demand for new weight-loss drugs, with the company pledging at least $27 billion for four new production sites.

Here’s what to know about Eli Lilly and the Alabama expansion.

Who is Eli Lilly? Inside one of America’s most influential drugmakers

Based in Indianapolis, Eli Lilly has been a pharmaceutical powerhouse for nearly 150 years. Its medicines now reach tens of millions of people worldwide. Focusing on diabetes, obesity, Alzheimer’s, immune disorders and hard-to-treat cancers, the company aims to turn complex dis

See Full Page